
The candidate vaccine’s next steps will be going through the FDA’s Biologics License Application process.
Keeping patients on long term therapy requires multifaceted interventions but even complex approaches don't lead to big improvements in adherence or improved outcomes, according to researchers from the McMaster University Faculty of Health Sciences in Ontario.






